alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 133.186 Sap sago cheese. ( a ) *Description.* ( 1 ) Sap sago cheese is the food prepared by the procedure set forth in paragraph (a)(2) of this section or by any other procedure which produces a finished cheese having the same physical and chemical properties. The cheese is pale green in color and has the shape of a truncated cone. The maximum moisture content is 38 percent by weight, as determined by the method described in § 133.5. Sap sago cheese is not less than 5 months old.
( 2 ) One or more of the dairy ingredients specified in paragraph (b)(1) of this section is allowed to become sour, and is heated to boiling temperature, with stirring. Sufficient sour whey is added to precipitate the casein. The curd is removed, spread out in boxes, and pressed, and while under pressure is allowed to drain and ferment. It is ripened for not less than 5 weeks. The ripened curd is dried and ground; salt and dried clover of the species *Melilotus coerulea* are added. The mixture is shaped into truncated cones and ripened. The optional ingredient in paragraph (b)(2) of this section may be added during this procedure.
( b ) *Optional ingredients.* The following safe and suitable ingredients may be used: ( 1 ) *Dairy ingredients.* Nonfat milk, as defined in § 133.3.
( 2 ) *Other optional ingredients.* Buttermilk.
( c ) *Nonmenclature.* The name of the food is “sap sago cheese”.
( d ) *Label declaration.* Each of the ingredients used in the food shall be declared on the label as required by the applicable sections of parts 101 and 130 of this chapter.
[54 FR 32058, Aug. 4, 1989, as amended at 58 FR 2895, Jan. 6, 1993]
Grant of Extension of Time

 PAGE 1

IN THE SUPREME COURT OF THE STATE OF MONTANA

No. DA 20-0405

IN THE MATTER OF:

A.J. and J.J, 

Youths in Need of Care.

GRANT OF EXTENSION OF TIME

Upon consideration of the Appellant’s Motion for Extension of Time, 

and good cause appearing therefore, the Appellant is granted an extension of 

time until December 7, 2020 to prepare, serve, and file the Opening Brief.

No further extensions will be granted.

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

November 11 2020

11/12/2020
# FILED

Janu ary 31, 1996 Cec il Cr ow son , Jr . Ap p e l l a te C o u rt C l e rk IN THE CO UR T OF CR IM IN AL AP PEALS OF TENN ESSEE AT JAC KSON NO VEM BER1995 SESSI ON
STATE OF TENN ESSEE , ) NO . 02C 01- 9506- CC -0 0178 ) Ap pe l l ee ) H AR D EM AN C OU N TY ) V. ) HO N. JO N KER RY BLAC KW OOD ) J U D G E CH AD D OU GLAS POOL E, ) ) (Se n te n cin g) Appel lan t )

CO NC UR RI NG OPI NI ON Like Jud ge Sum me rs, I fu lly agree w ith the conclusio n an d ration ale expressed in th e op inion wr itten byJudge W elles. Base d up on th e record in th is case and our Supreme C our

t' s o pin ion i n St ate v . Ad ams, 864 S. W .2d 3 1 ( Tenn. 1993 ), the "p articularly v ulne rable" enh ance me nt facto r w as no t shown to be ap plicable in this
cas e. In S tate v . Ad ams, Jus ti ce Drow ota, w ri ti ng for a unani mous C our t, sta ted: The factor

ca n be used

. . . if the ci rc umstan ces sh ow that the v ic ti m, bec ause of his ag e or phy si cal or

mental condi ti on, w as in fact "par ti cul ar ly v uln er abl e," i .e., inc apabl e of r esi sti ng , s ummoning hel p, or tes ti fyi ng ag ain st the p er petrator

. Stat e v . Ad ams, at 35

. As poi nted out b y

Ju dg e Summers, the y oung estv ic ti m in Adams w as four y ears o ld, but the C our t found t hat t he c hil d's ag e, s tandi ng al one, w as ins uff ic ien t
ev ide nce of his bei ng "par ti cul ar ly v uln er abl e." In t he presentca se, the v ic ti m w as a s ev enty -o ne- y ear-o ld female and her assailan t w as assiste d by the app ellant , a tw ent y -one -y ear-old m ale. T he e lderly
v ic ti m w as attac ked w it h a b aseba ll bat by su rp ri se w hen s he ent er ed her home an d found the a ppel lan t and hi s c o- defendant l y ing i n w aitfor h er
. Per haps our

Supreme C our

t w il l tak e thi s o ppor

tuni ty to furni sh g uid ance for low er co urts and t he bar

i n proper ly

appl y ing Sta te v . Ad ams i n the futur e.2 W ILLIA M M. BAR KER , J UD GE
[No. 39837-7-I.

Division One.

November 3, 1997.]

#### The State of Washington, *Respondent,*v. J.M., *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 96-8-04671-1, Anthony P. Wartnik, J., entered December 10, 1997. *Affirmed*by unpublished per curiam opinion.
[Federal Register Volume 75, Number 250 (Thursday, December 30, 2010)]
[Notices]
[Pages 82406-82407]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-32948]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0356]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Designated New Animal Drugs for 
Minor Use and Minor Species

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Designated New Animal Drugs for 
Minor Use and Minor Species'' has been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of 
Information Management, Food and Drug Administration, 1350 Piccard Dr., 
PI50-400B, Rockville, MD 20850, 301-796-3793.

SUPPLEMENTARY INFORMATION: In the Federal Register of September 28, 
2010 (75 FR 59721), the Agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0605. 
The approval expires on December 31, 2013. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.reginfo.gov/public/do/PRAMain.


[[Page 82407]]


    Dated: December 23, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2010-32948 Filed 12-29-10; 8:45 am]
BILLING CODE 4160-01-P
### Water resources of Windward Oahu, Hawaii

By: K. J. TakasakiGeorge Tokusuke HirashimaE.R. Lubke

                            https://doi.org/10.3133/wsp1894

#### Links

- More information:  **National Geologic Map Database Index Page**                            (html)
-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plates:                               - **Plate 1**                            (pdf)
  - **Plate 2**                            (pdf)
  - **Plate 3**                            (pdf) 
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
§ 1210.12 Physical examination of cows. ( a ) Physical examination of any and all cows in herds producing milk or cream which is to be shipped or transported into the United States shall be made by an authorized veterinarian of the United States or of any State or municipality thereof or of the country in which such milk or cream is produced to determine whether such cow or cows are in a healthy condition. Such examination shall be made as often as the Secretary may deem necessary and, in any event, shall have been made within one year previous to the time of the importation.
( b ) The result of the physical examination shall be set forth in the form prescribed by the Secretary.
<PAGE>   1
                                                                   EXHIBIT 23.1

                             CONSENT OF INDEPENDENT
                          CERTIFIED PUBLIC ACCOUNTANTS


The Board of Directors and Shareholders
Washington Banking Company:

     We consent to the use of our report incorporated herein by reference and
to the reference to our firm under the heading "Experts" in the prospectus.


/s/ KPMG PEAT MARWICK L.L.P.
Seattle, Washington
June 19, 1998
##### 



Exhibit 32.1 Certification Pursuant to 18 U.S.C. Section 1350. In connection with the Quarterly Report of Front Range Capital Corporation (the
Company) on Form 10-Q for the period ending June 30, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I,
William A. Mitchell, Jr. Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:  (1)
    
    The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in
all material respects, the financial condition and results of
operations of the Company. /s/ William A. Mitchell, Jr.

William A. Mitchell, Jr.
Chief Executive Officer
 A signed original of this written statement required by Section 906 has been
provided to Front Range Capital Corporation and will be retained by Front Range
Capital Corporation and furnished to the Securities and Exchange Commission or
its staff upon request.
§ 1305.14 Procedure for endorsing DEA Forms 222. ( a ) A DEA Form 222, made out to any supplier who cannot fill all or a part of the order within the time limitation set forth in § 1305.13, may be endorsed to another supplier for filling. The endorsement must be made only by the supplier to whom the DEA Form 222 was first made, must state (in the spaces provided in Part 3 on the original DEA Form 222) the DEA number of the second supplier, and must be signed and dated by a person authorized to obtain and execute DEA Forms 222 on behalf of the first supplier. The first supplier may not fill any part of an order on an endorsed form. The second supplier may fill the order, if possible and if the supplier desires to do so, in accordance with § 1305.13(b), (c), and (d), including shipping all substances directly to the purchaser.
( b ) Distributions made on endorsed DEA Forms 222 must be reported by the second supplier in the same manner as all other distributions.
[70 FR 16911, Apr. 1, 2005, as amended at 84 FR 51375, Sept. 30, 2019]
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<CIK>      0000945770
<NAME>     EVEREN CAPITAL CORPORATION
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                         DEC-31-1996
<PERIOD-START>                            JAN-01-1996
<PERIOD-END>                              DEC-31-1996
<CASH>                                     46,592,000 
<SECURITIES>                              160,940,000 
<RECEIVABLES>                             868,016,000 
<ALLOWANCES>                                        0
<INVENTORY>                                         0 
<CURRENT-ASSETS>                                    0       
<PP&E>                                     36,136,000      
<DEPRECIATION>                                      0    
<TOTAL-ASSETS>                          1,824,345,000      
<CURRENT-LIABILITIES>                               0    
<BONDS>                                             0  
<PREFERRED-MANDATORY>                               0 
<PREFERRED>                                         0 
<COMMON>                                      170,000 
<OTHER-SE>                                288,865,000       
<TOTAL-LIABILITY-AND-EQUITY>            1,824,345,000         
<SALES>                                   225,798,000          
<TOTAL-REVENUES>                          570,555,000          
<CGS>                                               0          
<TOTAL-COSTS>                             478,980,000          
<OTHER-EXPENSES>                                    0       
<LOSS-PROVISION>                                    0      
<INTEREST-EXPENSE>                         33,920,000       
<INCOME-PRETAX>                           107,836,000       
<INCOME-TAX>                               42,438,000      
<INCOME-CONTINUING>                        65,398,000      
<DISCONTINUED>                                      0  
<EXTRAORDINARY>                           (2,900,000)      
<CHANGES>                                           0  
<NET-INCOME>                               62,498,000 
<EPS-PRIMARY>                                    4.94 
<EPS-DILUTED>                                       0 
        

</TABLE>
<PAGE>   1


                                                                    EXHIBIT 16.2

                       [KPMG Peat Marwick LLP LETTERHEAD]



August 19, 1997

Securities and Exchange Commission
Washington, D.C. 20549

Ladies and Gentlemen:

We were previously principal accountants for Leading-Edge Earth Products, Inc.
and, under the date of October 7, 1996, we reported on the financial statements
of Leading-Edge Earth Products, Inc. as of and for the years ended April 30,
1996 and 1995. On June 16, 1997, we declined to stand for re-election. We have
read Leading-Edge Earth Products, Inc.'s statements included under Item 4 of its
Form 8-K/A dated August 18, 1997 and we agree with such statements, except that
we are not in a position to agree or disagree with Leading-Edge Earth Products,
Inc.'s statement that the change was approved at a meeting of the stockholders. 

Very truly yours,


KPMG Peat Marwick LLP
[Federal Register Volume 75, Number 7 (Tuesday, January 12, 2010)]
[Notices]
[Page 1684]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-375]


-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

United States Mint


Notification of Citizens Coinage Advisory Committee January 2010 
Public Meeting

ACTION: Notification of Citizens Coinage Advisory Committee January 
2010 Public Meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to United States Code, Title 31, section 
5135(b)(8)(C), the United States Mint announces the Citizens Coinage 
Advisory Committee (CCAC) public meeting scheduled for January 26, 
2010.
    Date: January 26, 2010.
    Time: 9 a.m.
    Location: Conference Room 5 North, United States Mint, 801 9th 
Street, NW., Washington, DC 20220.
    Subject: Review candidate designs for the 2011 America the 
Beautiful Quarters candidate designs for Gettysburg National Military 
Park, Glacier National Park, Olympic National Park, Vicksburg National 
Military Park, and Chickasaw National Recreation Area.
    Interested persons should call 202-354-7502 for the latest update 
on meeting time and room location.
    In accordance with 31 U.S.C. 5135, the CCAC:
    <bullet> Advises the Secretary of the Treasury on any theme or 
design proposals relating to circulating coinage, bullion coinage, 
Congressional Gold Medals, and national and other medals.
    <bullet> Advises the Secretary of the Treasury with regard to the 
events, persons, or places to be commemorated by the issuance of 
commemorative coins in each of the five calendar years succeeding the 
year in which a commemorative coin designation is made.
    <bullet> Makes recommendations with respect to the mintage level 
for any commemorative coin recommended.

FOR FURTHER INFORMATION CONTACT: Cliff Northup, United States Mint 
Liaison to the CCAC; 801 9th Street, NW.; Washington, DC 20220; or call 
202-354-7200.
    Any member of the public interested in submitting matters for the 
CCAC's consideration is invited to submit them by fax to the following 
number: 202-756-6830.

    Authority:  31 U.S.C. 5135(b)(8)(C).

    Dated: January 7, 2010.
Edmund C. Moy,
Director, United States Mint.
[FR Doc. 2010-375 Filed 1-11-10; 8:45 am]
BILLING CODE 4810-37-P
Editorial Note on Part 9
Editorial Note: Nomenclature changes to part 9 appear at 82 FR 52825, Nov. 15, 2017.

§ 9.90 Violations. ( a ) An injunction or other court order may be obtained pursuant to 5 U.S.C. 552a(g) (1-3) to compel NRC to permit an individual to review, amend or copy a record pertaining to him, or to be accompanied by someone of his or her own choosing when he or she reviews his or her record. A court order may be obtained for the payment of a civil penalty imposed pursuant to 5 U.S.C. 552a(g)(4) if NRC intentionally or willfully fails to maintain a record accurately, or fails to comply with any provision of 5 U.S.C. 552a, or any provision of this subpart, if such failure results in an adverse determination or has an adverse effect on an individual. Court costs and attorney's fees may be awarded in civil actions.
( b ) Any officer or employee of NRC who willfully maintains a system of records without meeting the notice requirements of 5 U.S.C. 552a(e)(4), or who willfully discloses information knowing such disclosure to be prohibited by 5 U.S.C. 552a or by any rules or regulations issued thereunder, may be guilty of a criminal misdemeanor and upon conviction may be fined up to $5000. Any person who knowingly and willfully requests or obtains any record concerning an individual from NRC under false pretenses may be convicted of a criminal misdemeanor and upon conviction may be fined up to $5,000.
EXHIBIT 99.2
                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection  with the Quarterly  Report of CirTran  Corporation on Form 10-QSB
for the period ending March 31, 2003, as filed with the  Securities and Exchange
Commission  on the date hereof (the  "Report"),  Iehab  Hawatmeh,  President and
Chief Executive Officer of the Company, certifies, pursuant to 18 U.S.C. Section
1350,  as adopted  pursuant  to Section 906 of the  Sarbanes-Oxley  Act of 2002,
that:

(1)  The Report fully complies with the  requirements  of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and result of operations of the Company.

May 19, 2003

                             /s/ Iehab Hawatmeh
                            ---------------------------------------------
                             Iehab J. Hawatmeh
                             President and Chief Financial Officer
Editorial Note on Part 173
Editorial Note: Nomenclature changes to part 173 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; and 81 FR 49896, July 29, 2016.

§ 173.170 Aminoglycoside 3′-phosphotransferase II. The food additive aminoglycoside 3′-phosphotransferase II may be safely used in the development of genetically modified cotton, oilseed rape, and tomatoes in accordance with the following prescribed conditions: ( a ) The food additive is the enzyme aminoglycoside 3′-phosphotransferase II (CAS Reg. No. 58943-39-8) which catalyzes the phosphorylation of certain aminoglycoside antibiotics, including kanamycin, neomycin, and gentamicin.
( b ) Aminoglycoside 3′-phosphotransferase II is encoded by the *kan* r gene originally isolated from transposon Tn*5* of the bacterium *Escherichia coli.*
( c ) The level of the additive does not exceed the amount reasonably required for selection of plant cells carrying the *kan* r gene along with the genetic material of interest.
[59 FR 26711, May 23, 1994]
§ 1313.24 Waiver of 15-day advance notice for chemical exporters. ( a ) Each regulated person shall provide to the Administration the identity and information listed in the definition of established business relationship in § 1300.02 of this chapter for an established business relationship with a foreign customer not later than August 31, 1989.
( b ) Not later than October 31, 1989, each regular customer so identified in notifications made under § 1313.24(a) shall be a regular customer for purposes of waiving the 15-day advance notice requirement, unless the regulated person is otherwise notified in writing by the Administration.
( c ) Each foreign customer identified on an initial DEA Form 486 submitted after the effective date of the implementation of part 1313 shall, after the expiration of the 15-day period, qualify as a regular customer, unless the Administration otherwise notifies the regulated person in writing.
( d ) Unless the Administration notifies the chemical exporter to the contrary, the qualification of a regular customer for any one of these three chemicals, acetone, 2-Butanone (MEK), or toluene, qualifies that customer as a regular customer for all three of these chemicals.
( e ) The Administrator may notify any chemical exporter that a regular customer has been disqualified or that a new customer for whom a notification has been submitted is not to be accorded the status of a regular customer. In the event of a disqualification of an established regular customer, the chemical exporter will be notified in writing of the reasons for such action.
[54 FR 31665, Aug. 1, 1989, as amended at 56 FR 55077, Oct. 24, 1991; 62 FR 13969, Mar. 24, 1997; 75 FR 10684, Mar. 9, 2010; 77 FR 4237, Jan. 27, 2012]
§ 225.35 Use of work areas, equipment, and storage areas for other manufacturing and storage purpose. ( a ) Many manufacturers of medicated feeds are also involved in the manufacture, storage, or handling of products which are not intended for animal feed use, such as fertilizers, herbicides, insecticides, fungicides, rodenticides, and other pesticides. Manufacturing, storage, or handling of nonfeed and feed products in the same facilities may cause adulteration of feed products with toxic or otherwise unapproved feed additives.
( b ) Work areas and equipment used for the manufacture or storage of medicated feeds or components thereof shall not be used for, and shall be physically separated from, work areas and equipment used for the manufacture of fertilizers, herbicides, insecticides, fungicides, rodenticides, and other pesticides unless such articles are approved drugs, indexed drugs, or approved food additives intended for use in the manufacture of medicated feed.
[41 FR 52618, Nov. 30, 1976, as amended at 72 FR 69120, Dec. 6, 2007]